Literature DB >> 20023382

Expression of CD133 correlates with differentiation of human colon cancer cells.

Hai-Liang Feng1, Yu-Qin Liu, Li-Juan Yang, Xiao-Cui Bian, Zhen-Li Yang, Bei Gu, Hong Zhang, Chun-Jing Wang, Xiao-Ling Su, Xiao-Mei Zhao.   

Abstract

CD133 has been identified as a cancer stem cell marker in colon and several other cancers, but its function is still unknown. We examined the CD133 expression in 44 human cancer cell lines, and found five of the 8 positive lines were from colon cancer. The CD133 positive subpopulation of colon cancer cells showed more vigorous growth and lower differentiation. Induction of differentiation reduced the CD133-positive population. Knockdown of CD133 expression in colon cancer cells could not induce cellular differentiation. Care must be taken if CD133 is used as the only marker of cancer stem cells in colon cancer, especially in established cell lines. CD133 negatively correlates with cell differentiation, but it is not a regulator of differentiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20023382     DOI: 10.4161/cbt.9.3.10664

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  18 in total

1.  Exosomes in colorectal carcinoma formation: ALIX under the magnifying glass.

Authors:  Gábor Valcz; Orsolya Galamb; Tibor Krenács; Sándor Spisák; Alexandra Kalmár; Árpád V Patai; Barna Wichmann; Kristóf Dede; Zsolt Tulassay; Béla Molnár
Journal:  Mod Pathol       Date:  2016-05-06       Impact factor: 7.842

Review 2.  Ovarian cancer stem cell markers: prognostic and therapeutic implications.

Authors:  Daniela Burgos-Ojeda; Bo R Rueda; Ronald J Buckanovich
Journal:  Cancer Lett       Date:  2012-02-11       Impact factor: 8.679

Review 3.  CD133: a cancer stem cells marker, is used in colorectal cancers.

Authors:  Fei Ren; Wei-Qi Sheng; Xiang Du
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

4.  Associations between markers of colorectal cancer stem cells and adenomas among ethnic groups.

Authors:  Bonita J Leavell; Eric Van Buren; Fadi Antaki; Bradley N Axelrod; Mary Ann Rambus; Adhip P N Majumdar
Journal:  Dig Dis Sci       Date:  2012-05-06       Impact factor: 3.199

Review 5.  Colon cancer stem cells: implications in carcinogenesis.

Authors:  Matthew A Sanders; Adhip P N Majumdar
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

6.  Quercetin induces cell cycle arrest and apoptosis in CD133(+) cancer stem cells of human colorectal HT29 cancer cell line and enhances anticancer effects of doxorubicin.

Authors:  Shekoufeh Atashpour; Shamileh Fouladdel; Tahereh Komeili Movahhed; Elmira Barzegar; Mohammad Hossein Ghahremani; Seyed Nasser Ostad; Ebrahim Azizi
Journal:  Iran J Basic Med Sci       Date:  2015-07       Impact factor: 2.699

7.  Response to stress in early tumor colonization modulates switching of CD133-positive and CD133-negative subpopulations in a human metastatic colon cancer cell line, SW620.

Authors:  Chih-Sin Hsu; Chien-Yi Tung; Chih-Yung Yang; Chi-Hung Lin
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

8.  Significance of CD133 expression in esophageal squamous cell carcinoma.

Authors:  Hiroshi Okamoto; Fumiyoshi Fujishima; Yasuhiro Nakamura; Masashi Zuguchi; Yohei Ozawa; Yayoi Takahashi; Go Miyata; Takashi Kamei; Toru Nakano; Yusuke Taniyama; Jin Teshima; Mika Watanabe; Akira Sato; Noriaki Ohuchi; Hironobu Sasano
Journal:  World J Surg Oncol       Date:  2013-03-01       Impact factor: 2.754

9.  Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients.

Authors:  Claudio Coco; Gian Franco Zannoni; Emanuele Caredda; Stefano Sioletic; Alma Boninsegna; Mario Migaldi; Gianluca Rizzo; Luca Reggiani Bonetti; Giannicola Genovese; Egidio Stigliano; Achille Cittadini; Alessandro Sgambato
Journal:  J Exp Clin Cancer Res       Date:  2012-09-11

10.  Hes1 is involved in the self-renewal and tumourigenicity of stem-like cancer cells in colon cancer.

Authors:  Fei Gao; YuQin Zhang; ShengChun Wang; YuanQiang Liu; Lin Zheng; JianQuan Yang; Wei Huang; YanFen Ye; WeiRen Luo; Dong Xiao
Journal:  Sci Rep       Date:  2014-02-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.